{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:58:34Z","timestamp":1791655114382,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Sichuan Provincial Science and Technology Department","award":["2023NSFSC1666"],"award-info":[{"award-number":["2023NSFSC1666"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16487-3","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T14:46:20Z","timestamp":1755787580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aqueous carbonic anhydrase-1 overexpression and its association with cytokine profiles and macular structural changes in retinal vein occlusion-associated macular edema"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaoshuang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"7","key":"16487_CR1","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1097\/HJH.0000000000002057","volume":"37","author":"KA Ponto","year":"2019","unstructured":"Ponto, K. A. et al. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg retinal vein occlusion study. J. Hypertens. 37 (7), 1372\u20131383 (2019).","journal-title":"J. Hypertens."},{"issue":"4","key":"16487_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.hipert.2018.12.004","volume":"36","author":"M Lisa Gracia","year":"2019","unstructured":"Lisa Gracia, M., Vieitez Santiago, M., Salm\u00f3n Gonzalez, Z., Qiu Liu, S. & Hern\u00e1ndez Hern\u00e1ndez, J. L. Napal lecumberri JJ. [Hypertension and Framingham general vascular risk score in retinal vein occlusion]. Hipertens Riesgo Vasc. 36 (4), 193\u2013198 (2019).","journal-title":"Hipertens Riesgo Vasc"},{"issue":"5","key":"16487_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10384-019-00676-5","volume":"63","author":"Y Muraoka","year":"2019","unstructured":"Muraoka, Y. & Tsujikawa, A. Arteriovenous crossing associated with branch retinal vein occlusion. Jpn J. Ophthalmol. 63 (5), 353\u2013364 (2019).","journal-title":"Jpn J. Ophthalmol."},{"issue":"5","key":"16487_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/00006982-200110000-00002","volume":"21","author":"EM Opremcak","year":"2001","unstructured":"Opremcak, E. M. et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 21 (5), 408\u2013415 (2001).","journal-title":"Retina"},{"issue":"3","key":"16487_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/IAE.0000000000000843","volume":"36","author":"M Ho","year":"2016","unstructured":"Ho, M., Liu, D. T., Lam, D. S. & Jonas, J. B. Retinal vein occlusions, from basics to the latest treatment. Retina 36 (3), 432\u2013448 (2016).","journal-title":"Retina"},{"issue":"4","key":"16487_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/bjophthalmol-2017-311805","volume":"103","author":"C Busch","year":"2019","unstructured":"Busch, C. et al. Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant. Br. J. Ophthalmol. 103 (4), 463\u2013468 (2019).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"16487_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/09286586.2020.1792937","volume":"28","author":"HDJ Hogg","year":"2021","unstructured":"Hogg, H. D. J., Talks, S. J., Pearce, M. & Di Simplicio, S. Real-World visual and neovascularisation outcomes from anti-VEGF in central retinal vein occlusion. Ophthalmic Epidemiol. 28 (1), 70\u201376 (2021).","journal-title":"Ophthalmic Epidemiol."},{"key":"16487_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11099-017-0685-4","volume":"55","author":"E Kupriyanova","year":"2017","unstructured":"Kupriyanova, E. Carbonic anhydrase \u2013 a universal enzyme of the carbon-based life. Photosynthetica 55, 3\u201319 (2017).","journal-title":"Photosynthetica"},{"issue":"2","key":"16487_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov. 7 (2), 168\u2013181 (2008).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"2","key":"16487_CR10","doi-asserted-by":"publisher","first-page":"e000434","DOI":"10.1161\/JAHA.113.000434","volume":"3","author":"D Torella","year":"2014","unstructured":"Torella, D. et al. Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy. J. Am. Heart Assoc. 3 (2), e000434 (2014).","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"16487_CR11","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.4103\/IJO.IJO_276_23","volume":"71","author":"S Sen","year":"2023","unstructured":"Sen, S. et al. Comparative proteomics of proliferative diabetic retinopathy in people with type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways. Indian J. Ophthalmol. 71 (8), 3069\u20133079 (2023).","journal-title":"Indian J. Ophthalmol."},{"issue":"3","key":"16487_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/imt.11.4","volume":"3","author":"M Tomita","year":"2011","unstructured":"Tomita, M. & Tsumoto, K. Hybridoma technologies for antibody production. Immunotherapy 3 (3), 371\u2013380 (2011).","journal-title":"Immunotherapy"},{"issue":"Suppl 1","key":"16487_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000315155","volume":"224","author":"S Scholl","year":"2010","unstructured":"Scholl, S., Kirchhof, J. & Augustin, A. J. Pathophysiology of macular edema. Ophthalmologica 224 (Suppl 1), 8\u201315 (2010).","journal-title":"Ophthalmologica"},{"issue":"3","key":"16487_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","volume":"105","author":"J Pe\u2019er","year":"1998","unstructured":"Pe\u2019er, J. et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105 (3), 412\u2013416 (1998).","journal-title":"Ophthalmology"},{"issue":"1","key":"16487_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma, H. et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond). 22 (1), 42\u201348 (2008).","journal-title":"Eye (Lond)"},{"issue":"7","key":"16487_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/eye.2009.340","volume":"24","author":"A Fonollosa","year":"2010","unstructured":"Fonollosa, A. et al. Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular oedema with branch retinal vein occlusion. Eye (Lond). 24 (7), 1284\u20131290 (2010).","journal-title":"Eye (Lond)"},{"issue":"2","key":"16487_CR17","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1111\/j.1755-3768.2011.02292.x","volume":"90","author":"MJ Koss","year":"2012","unstructured":"Koss, M. J. et al. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion. Acta Ophthalmol. 90 (2), e98\u2013e103 (2012).","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"16487_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1167\/iovs.08-2510","volume":"50","author":"M Funk","year":"2009","unstructured":"Funk, M. et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest. Ophthalmol. Vis. Sci. 50 (3), 1025\u20131032 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"16487_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874364101307010011","volume":"7","author":"M Koss","year":"2013","unstructured":"Koss, M. et al. Correlation from undiluted vitreous cytokines of untreated central retinal vein occlusion with spectral domain optical coherence tomography. Open. Ophthalmol. J. 7, 11\u201317 (2013).","journal-title":"Open. Ophthalmol. J."},{"issue":"2","key":"16487_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/2013.jamaophthalmol.228","volume":"131","author":"H Noma","year":"2013","unstructured":"Noma, H., Mimura, T. & Eguchi, S. Association of inflammatory factors with macular edema in branch retinal vein occlusion. JAMA Ophthalmol. 131 (2), 160\u2013165 (2013).","journal-title":"JAMA Ophthalmol."},{"key":"16487_CR21","doi-asserted-by":"publisher","first-page":"1326633","DOI":"10.3389\/fmolb.2023.1326633","volume":"10","author":"CT Supuran","year":"2023","unstructured":"Supuran, C. T. Carbonic anhydrase versatility: from pH regulation to CO(2) sensing and metabolism. Front. Mol. Biosci. 10, 1326633 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"16487_CR22","doi-asserted-by":"crossref","unstructured":"Noma, N. et al. Impact of acetazolamide, a carbonic anhydrase inhibitor, on the development of intestinal polyps in min mice. Int. J. Mol. Sci 18(4) (2017).","DOI":"10.3390\/ijms18040851"},{"issue":"2","key":"16487_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1534","volume":"13","author":"BB Gao","year":"2007","unstructured":"Gao, B. B. et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 13 (2), 181\u2013188 (2007).","journal-title":"Nat. Med."},{"issue":"8","key":"16487_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood.2019002224","volume":"135","author":"I Ivanov","year":"2020","unstructured":"Ivanov, I. et al. Protease activity in single-chain prekallikrein. Blood 135 (8), 558\u2013567 (2020).","journal-title":"Blood"},{"issue":"5","key":"16487_CR25","doi-asserted-by":"publisher","first-page":"e20036","DOI":"10.1371\/journal.pone.0020036","volume":"6","author":"J Dob\u00f3","year":"2011","unstructured":"Dob\u00f3, J. et al. Cleavage of kininogen and subsequent Bradykinin release by the complement component: mannose-binding lectin-associated Serine protease (MASP)-1. PLoS One. 6 (5), e20036 (2011).","journal-title":"PLoS One"},{"issue":"19","key":"16487_CR26","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1182\/blood-2012-06-440057","volume":"120","author":"F Langhauser","year":"2012","unstructured":"Langhauser, F. et al. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation. Blood 120 (19), 4082\u20134092 (2012).","journal-title":"Blood"},{"issue":"3","key":"16487_CR27","first-page":"734","volume":"7","author":"TA Martin","year":"2001","unstructured":"Martin, T. A., Mansel, R. & Jiang, W. G. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells. Clin. Cancer Res. 7 (3), 734\u2013737 (2001).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"16487_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbrc.2005.09.028","volume":"337","author":"R Rosenthal","year":"2005","unstructured":"Rosenthal, R. et al. The fibroblast growth factor receptors, FGFR-1 and FGFR-2, mediate two independent signalling pathways in human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 337 (1), 241\u2013247 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"16487_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2353\/ajpath.2006.050479","volume":"168","author":"SI Zittermann","year":"2006","unstructured":"Zittermann, S. I. & Issekutz, A. C. Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am. J. Pathol. 168 (3), 835\u2013846 (2006).","journal-title":"Am. J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16487-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16487-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16487-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:59:17Z","timestamp":1757411957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16487-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16487"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16487-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol used in this study was approved by the Institutional Review Board of West China Hospital (2023\u2009\u2212\u20091375), and the procedures conformed to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"30780"}}